Brief: Prostatype Genomics Says Potential U.S. Tariffs Have Minimal Effect On Co Operations In U.S.
April 4 (Reuters) - Prostatype Genomics AB PROGEN.ST: POTENTIAL U.S. TARIFFS HAVE MINIMAL EFFECT ON PROSTATYPE GENOMICS' OPERATIONS IN THE U.S. YESTERDAY'S PROPOSED U.S. TARIFFS OF 20 PERCENT ON GOODS IMPORTED FROM EU HAVE ALMOST NO EFFECT ON COMPANY'S U.S. OPERATIONS EXPECTS U.S. TO BECOME MAIN MARKET FROM 2025 Source text: ID:nMFN6x2l9Z Further company coverage: PROGEN.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue